What PEMF UK is
PEMF UK is an independent UK editorial site about Pulsed Electromagnetic Field therapy and related magnetic-stimulation modalities (rTMS, T-PEMF, tDCS). We exist because the consumer-facing PEMF conversation in the UK is dominated by marketing pages from device manufacturers and clinics — most of which overpromise, and few of which cite primary evidence or UK regulatory context. We try to do the opposite: cite primary trials (including negative ones), reflect NICE guidance and ASA rulings honestly, and signpost readers back to the NHS pathway and qualified medical advice where appropriate.
What we are not
We are not doctors, nurses, or any other regulated healthcare professionals. The content on this site is editorial — it is not medical advice and it is not a substitute for medical advice. We do not sell PEMF or rTMS devices, we do not own a PEMF clinic, and we do not provide treatment of any kind. We do operate a free clinic directory listing PEMF practitioners across the UK; clinics are listed under our editorial terms but their treatment claims are their own responsibility.
Who writes the content
The site is produced by the PEMF UK Editorial Team — a small group of independent editors based in the UK with backgrounds in technology, health journalism and information science. We are not a medical practice. Where the content discusses clinical evidence we cite primary sources (PubMed-indexed RCTs, meta-analyses, NICE guidance, MHRA classification, ASA rulings, NHS commissioning documents, FDA briefing documents). Where we summarise the implications of that evidence, we do so as informed editorial — not as professional medical advice. Disagreements with our interpretation are welcome — see "Corrections and complaints" below.
Our editorial position on PEMF
The evidence base for PEMF and magnetic stimulation is genuinely mixed and varies sharply by condition, device class, and patient population. We hold three editorial positions consistently across the site:
- Three device classes are not interchangeable. Clinical rTMS (1-2 Tesla, NICE-recognised for depression), research-grade T-PEMF (used in Danish Parkinson's trials), and low-intensity consumer PEMF (microtesla wellness mats) have different evidence bases. Conflating them is the single commonest error in PEMF marketing.
- Negative trials matter. Wei 2024 (rTMS for Alzheimer's, null), NICHE 2018 (chronic-stroke rTMS, null), Salfinger 2015 (NMR for disc herniation, null on MCID) and others appear on the relevant pages by design. An evidence summary that only cites positive trials does not survive scrutiny.
- NICE, NHS and ASA frame the UK conversation. Whatever the published trial evidence shows, UK marketing is bound by ASA CAP Code Section 12, devices are bound by MHRA classification, and the NHS pathway is defined by NICE guidance. We cite all four consistently.
Funding and commercial relationships
PEMF UK earns nothing from device sales and accepts no funding from device manufacturers. Our only present revenue stream is the clinic directory — currently free during the launch period; future paid tiers will be disclosed in advance. We track outbound clicks from clinic listings to clinic websites via a redirect URL on our own domain (pemfanswers.com/go/[slug]) — standard web analytics with no personal data captured. We have no editorial relationship with any device manufacturer. If we cite a study sponsored by a manufacturer (e.g. NeuroAD trials, T-PEMF trials from Re5), we note the conflict of interest.
Editorial process
Every clinical claim on this site is cited to a primary source linked in the page footer. Pages are reviewed every six months (see the "next review" date in each page's editorial-standards block). When new pivotal trials publish (e.g. the 2024 Wei rTMS null, the 2025 Koch 52-week precuneus extension), we update the relevant pages. We deliberately include negative or null trials in our evidence tables. We do not use generative AI to write content claims; we use it as a research assistant for finding citations, which we then verify by hand.
Corrections and complaints
If you find an error of fact on any page — a misquoted trial result, a missed citation, an out-of-date regulatory position — please tell us. We will correct promptly and credit the correction visibly. If you have a complaint about a clinic listed in our directory, please raise it with the clinic first; if unresolved we will review the listing under our listing terms. Contact: [email protected].
What you should do with our content
Use it as an evidence-aware orientation map, not as a treatment plan. If you are considering PEMF, rTMS or any related intervention for yourself or someone you care for, the highest-yield step is a conversation with your GP, specialist nurse, or consultant — armed with the questions our pages prompt. We are most useful as preparation for that conversation, not as a substitute for it.